Jinling Pharmaceutical Company Limited (SHE:000919)

SHE:000919 Revenue

Jinling Pharmaceutical Company had revenue of 768.67M CNY in the quarter ending March 31, 2026, a decrease of -5.10%. This brings the company's revenue in the last twelve months to 3.16B, down -2.76% year-over-year. In the year 2025, Jinling Pharmaceutical Company had annual revenue of 3.20B, down -2.56%.

• Revenue (ttm): 3.16B
• Revenue Growth: -2.76%
• P/S Ratio: 1.34
• Revenue / Employee: 552.13K
• Employees: 5,716
• Market Cap: 4.22B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.20B	-84.13M	-2.56%
Dec 31, 2024	3.28B	87.45M	2.74%
Dec 31, 2023	3.19B	523.03M	19.58%
Jan 1, 2023	2.67B	-137.79M	-4.91%
Jan 1, 2022	2.81B	305.02M	12.18%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 17, 2026

Data Sources Report a data error